Newsoara HYK Biopharmaceutical (Shanghai) Co., Ltd.
Newsoara HYK Biopharmaceutical (Shanghai) Co., Ltd.
Explore linked clinical trials.1 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Olvi-Vec Combined With Platinum Plus Etoposide Therapy in Patients With Late Phase SCLC | SCLC, Extensive Stage | Recruiting | Phase 1 / Phase 2 | 2025-12-03 | NCT07136285 |